| Page | ||
|---|---|---|
| Reference and Administrative Details ofthe Charity, its Trustees and Advisers |
||
| Trustees' Report |
2-15 | |
| Independent Examiner's |
Report | 16 |
| Statement of Financial | Activities | 17 |
| Balance Sheet | 18-19 | |
| Notes to the Financial Statements | 20-33 |
| uring the reporting period, whic |
h would normally b |
e a major reas | on for postgrad | uates to joi |
|---|---|---|---|---|
| Sept 2020 | Sep-21 | Change | ||
| Full Members | 583 | 594 | +11 | 102% |
| Early Career Researchers | 311 | 311 | 100% | |
| Career starter | n/a | 19 | +19 | |
| Postgraduate | 757 | 615 | -142 | 81% |
| Student/Undergraduate | 634 | 749 | +115 | 118% |
| Industry member |
27 | 47 | +20 | 174% |
| Associate member | 67 | 73 | +6 | 109% |
| Retired member | 46 | 52 | +6 | 113% |
| Honorary member |
86% | |||
| TOTAL | 2,432 | 2,466 | +34 | 101.4% |
| Unrestricted | Restricted | Total | Total | ||||
|---|---|---|---|---|---|---|---|
| funds | funds | funds | funds | ||||
| 2021 | 2021 | 2021 | 2020 | ||||
| Note | |||||||
| Income from: | |||||||
| Donations and legacies |
44,880 | 20,166 | 65,046 | 14,796 | |||
| Charitable activities |
98,224 | 98,224 | 95,307 | ||||
| Investments | 227 | 227 | 113,876 | ||||
| Total income | 143,331 | 20,166 | 163,497 | 223,979 | |||
| Expenditure on: |
|||||||
| Charitable activities |
115,690 | 135,060 | 250,750 | 233,414 | |||
| Total expenditure | 115,690 | 135,060 | 250,750 | 233,414 | |||
| Net income/(expenditure) | before net | ||||||
| gains/(losses) on |
investments | 27,641 | (114,894) | (87,253) | (9,435) | ||
| Net gains/(losses) | on investments | 62,111 | 62,111 | (14,099) | |||
| Net movement in |
funds | 89,752 | (114,894) | (25,142) | (23,534) | ||
| Reconciliation of |
funds: | ||||||
| Total funds brought | forward | 402,202 | 166,550 | 568,752 | 592,286 | ||
| Net movement in funds |
89,752 | (114,894) | (25,142) | (23,534) | |||
| Total funds carried forward | 491,954 | 51,656 | 543,610 | 568,752 |
| Unrestricted | Restricted | Total | Total | ||
|---|---|---|---|---|---|
| funds | funds | funds | funds | ||
| 2021 | 2021 | 2021 | 2020 | ||
| f. | F | f. | |||
| Donations | 43,146 | 20,166 | 63,312 | 14,796 | |
| Government | grants | 1,734 | 1,734 | ||
| 44,880 | 20,166 | 65,046 | 14,796 | ||
| Total 2020 | 293 | 14,503 | 14,796 |
| Unrestricted | Total | Total | ||
|---|---|---|---|---|
| funds | funds | funds | ||
| 2021 | 2021 | 2020 | ||
| Subscriptions | and Bulletin advertising | 98,224 | 98,224 | 95,307 |
| Total 2020 | 95,307 | 95,307 |
| Unrestricted | Total | Total | ||
|---|---|---|---|---|
| funds | funds | funds | ||
| 2021f | 2021 f. |
2020 | ||
| Dividend | income | 113,435 | ||
| Bank interest | 227 | 227 | 441 | |
| 227 | 227 | 113,876 | ||
| Total 2020 | 113,876 | 113,876 |
| Unrestricted | Restricted | Total | Total | |||
|---|---|---|---|---|---|---|
| funds | funds | funds | funds | |||
| 2021f | 2021f | 2021f | 2020 | |||
| Advance | education | in neuroscience | 115,690 | 135,060 | 250,750 | 233,414 |
| Total 2020 | 124,800 | 108,614 | 233,414 |
| Activities | ||||||
|---|---|---|---|---|---|---|
| undertaken | Support | Total | Total | |||
| directly | costs | funds | funds | |||
| 2021 f. |
2021f | 2021 f. |
2020 | |||
| Advance | education | in neuroscience | 170,347 | 80,403 | 250,750 | 233,414 |
| Total 2020 | 137,460 | 95,954 | 233,414 |
| Advance | |||||
|---|---|---|---|---|---|
| education in |
Total | Total | |||
| neuroscience | funds | funds | |||
| 2021 | 2021 | 2020 | |||
| f. | F | ||||
| Staff costs | 122,302 | 122,302 | 72,420 | ||
| Bulletin | production | 27,797 | 27,797 | 26,746 | |
| Bursaries and | sponsorship | 2,436 | 2,436 | 8,486 | |
| Gatsby | project | costs | 4,407 | 4,407 | 7,509 |
| Subscriptions | and membership | 5,054 | 5,054 | 5,967 | |
| Advertising | 1,750 | 1,750 | 8,976 | ||
| Travel | 1,153 | 1,153 | 517 | ||
| Printing, | postage and stationery | 811 | 811 | 1,827 | |
| Telephone | 512 | ||||
| Journal | production | 4,637 | 4,637 | 4,500 | |
| 170,347 | 170,347 | 137,460 | |||
| Total 2020 | 137,460 | 137,460 |
| Advance | ||||
|---|---|---|---|---|
| education in |
Total | Total | ||
| neuroscience | funds | funds | ||
| 2021 | 2021 | 2020 | ||
| f. | F | |||
| Staff costs | 67,390 | 67,390 | 65,771 | |
| Depreciation | 450 | 450 | 900 | |
| Advertising | 605 | 605 | 9,693 | |
| Travel | 72 | 72 | 1,381 | |
| Printing, postage and stationery |
131 | 131 | 133 | |
| Telephone | 635 | 635 | 589 | |
| Website development | (1,870) | (1,870) | 3,312 | |
| Professional | fees | 7,267 | 7,267 | 7,213 |
| Insurance | 707 | 707 | 1,414 | |
| Bank charges | 3,086 | 3,086 | 2,285 | |
| Sundry | 355 | 355 | 644 | |
| Governance | 2,000 | 2,000 | 2,000 | |
| Bad debt | (425) | (425) | 619 | |
| 80,403 | 80,403 | 95,954 | ||
| Total 2020 | 95,954 | 95,954 |
| taff costs | |||||
|---|---|---|---|---|---|
| 2021 | 2020 | ||||
| f. | |||||
| Wages and | salaries | 169,913 | 122,102 | ||
| Social security costs | 12,158 | 8,035 | |||
| Contribution | to defined | contribution | pension schemes | 7,621 | 8,054 |
| 189,692 | 138,191 |
| Office | |
|---|---|
| equipment | |
| F | |
| Cost or valuation | |
| At 1 October 2020 | 4,355 |
| At 30September 2021 | 4,355 |
| Depreciation | |
| At 1 October 2020 | 2,102 |
| Charge for the year | 450 |
| At 30September 2021 | 2,552 |
| Net book value | |
| At 30September 2021 | 1,803 |
| At 30September 2020 | 2,253 |
| Investments | |||
|---|---|---|---|
| in | |||
| subsidiary | Other | ||
| companies | investments | Total | |
| F | f. | F | |
| Cost or valuation | |||
| At 1 October 2020 | 100 | 301,068 | 301,168 |
| Revaluations | 62,111 | 62,111 | |
| At 30September 2021 | 100 | 363,179 | 363,279 |
| Net book value | |||
| At 30September 2021 | 100 | 363,179 | 363,279 |
| At 30September 2020 | 100 | 301,068 | 301,168 |
| Principal subsidiaries |
| The following | was a subsidiary undert |
aking ofthe Charity: |
||||
|---|---|---|---|---|---|---|
| Name | Company | Holding | Included | in | ||
| number | consolidation | |||||
| BNA Events | Limited | 07784689 | 100'/o | No | ||
| The financial | results ofthe subsidiary | for the year were: | ||||
| Name | Profit/(Loss) | Net | assets | |||
| for the year | F | |||||
| f. | ||||||
| BNA Events | Limited | 103,527 | 98,592 |
| 2021 | 2020 | ||
|---|---|---|---|
| f. | |||
| Due within one year | |||
| Trade debtors | 32,409 | 1,149 | |
| Amounts owed by group undertakings |
48,376 | 53,860 | |
| Other debtors | 496 | ||
| Prepayments | and accrued income | 1,614 | 1,668 |
| 82,895 | 56,677 |
| 2021 | 2020 | ||
|---|---|---|---|
| Trade creditors | 601 | 2,782 | |
| PAYE and social security | 3,850 | ||
| Other creditors | 39,063 | ||
| Accruals and deferred | income | 10,761 | 11,417 |
| 11,362 | 57,112 |
| Statem | ent | off | un | ds - current | year | ||||
|---|---|---|---|---|---|---|---|---|---|
| Balance at | |||||||||
| Balance at 1 | 30 | ||||||||
| October | Gains/ | September | |||||||
| 2020 | Income | Expenditure | (Losses) | 2021 | |||||
| F | f. | F | f. | F | |||||
| Unrestricted | funds | ||||||||
| General | Funds | - | all funds | 402,202 | 143,331 | (115,690) | 62,111 | 491,954 | |
| Restricted | funds | ||||||||
| Wolstencroft | fund | 6,500 | 6,500 | ||||||
| Journal | fund | 3,104 | 4,637 | (7,741) | |||||
| Society | for Neuroscience | 506 | (506) | ||||||
| Roche | Products | 5,855 | (5,855) | ||||||
| Gatsby | Charitable | Foundation | 150,585 | (115,221) | 35,364 | ||||
| Guarantors | of Brain | 10,000 | (208) | 9,792 | |||||
| Equity, | diversity | and inclusion | |||||||
| (EDI) | 5,529 | (5,529) | |||||||
| 166,550 | 20,166 | (135,060) | 51,656 | ||||||
| Total funds | 568,752 | 163,497 | (250,750) | 62,111 | 543,610 |
| Statement | offun | ds - prior year | |||||
|---|---|---|---|---|---|---|---|
| Balance at | |||||||
| Balance at | 30 | ||||||
| 1 October | Transfers | Gains' | September | ||||
| 2019 | Income | Expenditure | in!out | (Losses) | 2020 | ||
| Unrestricted | |||||||
| funds | |||||||
| General Funds |
|||||||
| - all funds | 326,004 | 209,476 | (124,800) | 5,621 | (14,099) | 402,202 | |
| Restricted | |||||||
| funds | |||||||
| Wolstencroft | |||||||
| fund | 6,500 | 6,500 | |||||
| Journal fund |
3,101 | 4,503 | (4,500) | 3,104 | |||
| Society for | |||||||
| Neuroscience | 506 | 506 | |||||
| Roche Products | 14,342 | (8,486) | 5,856 | ||||
| Gatsby | |||||||
| Charitable | |||||||
| Foundation | 241,833 | (91,249) | 150,584 | ||||
| Guarantors | of | ||||||
| Brain | 10,000 | (4,379) | (5,621) | ||||
| 266,282 | 14,503 | (108,614) | (5,621) | 166,550 | |||
| Total funds | 592,286 | 14,503 | (233,414) | (14,099) | 568,752 |
| Analysis of net assets between funds - cur | rent year | ||
|---|---|---|---|
| Unrestricted | Restricted | Total | |
| funds | funds | funds | |
| 2021 | 2021 | 2021 | |
| F | f. | F | |
| Tangible fixed assets | 1,803 | 1,803 | |
| Fixed asset investments | 363,279 | 363,279 | |
| Current assets | 138,234 | 51,656 | 189,890 |
| Creditors due within one year | (11,362) | (11,362) | |
| Total | 491,954 | 51,656 | 543,610 |
| Unrestricted | Restricted | Total | |
|---|---|---|---|
| funds | funds | funds | |
| 2020 | 2020 | 2020 | |
| Tangible fixed assets | 2,253 | 2,253 | |
| Fixed asset investments | 301,168 | 301,168 | |
| Current assets | 130,606 | 191,837 | 322,443 |
| Creditors due within one year | (31,825) | (25,287) | (57,112) |
| Tl | 402,202 | 166,550 | 568,752 |